Observational study with everolimus (Certican) in combination with low-dose cyclosporine in de novo heart transplant recipients. (Q52925202)

From Wikidata
Jump to navigation Jump to search
scientific article published on 6 April 2007
edit
Language Label Description Also known as
English
Observational study with everolimus (Certican) in combination with low-dose cyclosporine in de novo heart transplant recipients.
scientific article published on 6 April 2007

    Statements

    Observational study with everolimus (Certican) in combination with low-dose cyclosporine in de novo heart transplant recipients. (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit